Skip to main content
NCBI home page
Canadian Family Physician logoLink to Canadian Family Physician
. 1991 Mar;37:685–693.

Drug Treatment of Hypertension

Controlling elevated blood pressure

Douglas R Ryan
PMCID: PMC2145283  PMID: 21229011

Abstract

Hypertension is an important contributor to cardiovascular disease, which accounts for about half of all deaths in Western societies. Proper control of elevated blood pressure is therefore important. Support has grown for an approach to care in which antihypertensive drug therapy is individually tailored for each patient. Management strategy based on this approach is discussed, and the advantages and disadvantages of the various antihypertensive agents are reviewed.

Full text

PDF
685

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Collins R., Yusuf S., Peto R. Overview of randomised trials of diuretics in pregnancy. Br Med J (Clin Res Ed) 1985 Jan 5;290(6461):17–23. doi: 10.1136/bmj.290.6461.17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Croog S. H., Levine S., Testa M. A., Brown B., Bulpitt C. J., Jenkins C. D., Klerman G. L., Williams G. H. The effects of antihypertensive therapy on the quality of life. N Engl J Med. 1986 Jun 26;314(26):1657–1664. doi: 10.1056/NEJM198606263142602. [DOI] [PubMed] [Google Scholar]
  3. Frishman W. H., Furberg C. D., Friedewald W. T. Beta-adrenergic blockade for survivors of acute myocardial infarction. N Engl J Med. 1984 Mar 29;310(13):830–837. doi: 10.1056/NEJM198403293101306. [DOI] [PubMed] [Google Scholar]
  4. Groop L., Tötterman K. J., Harno K., Gordin A. Influence of beta-blocking drugs on glucose metabolism in patients with non-insulin dependent diabetes mellitus. Acta Med Scand. 1982;211(1-2):7–12. doi: 10.1111/j.0954-6820.1982.tb01893.x. [DOI] [PubMed] [Google Scholar]
  5. Hamet P., Kalant N., Ross S. A., Wilson T. W., Leenen F. H., Haynes R. B. Recommendations from the Canadian Hypertension Society Consensus Conference on Hypertension and Diabetes. CMAJ. 1988 Dec 1;139(11):1059–1062. [PMC free article] [PubMed] [Google Scholar]
  6. Holland O. B., von Kuhnert L., Campbell W. B., Anderson R. J. Synergistic effect of captopril with hydrochlorothiazide for the treatment of low-renin hypertensive black patients. Hypertension. 1983 Mar-Apr;5(2):235–239. doi: 10.1161/01.hyp.5.2.235. [DOI] [PubMed] [Google Scholar]
  7. Hommel E., Parving H. H., Mathiesen E., Edsberg B., Damkjaer Nielsen M., Giese J. Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy. Br Med J (Clin Res Ed) 1986 Aug 23;293(6545):467–470. doi: 10.1136/bmj.293.6545.467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hricik D. E., Browning P. J., Kopelman R., Goorno W. E., Madias N. E., Dzau V. J. Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenoses or renal-artery stenosis in a solitary kidney. N Engl J Med. 1983 Feb 17;308(7):373–376. doi: 10.1056/NEJM198302173080706. [DOI] [PubMed] [Google Scholar]
  9. Kaplan N. M. Calcium entry blockers in the treatment of hypertension. Current status and future prospects. JAMA. 1989 Aug 11;262(6):817–823. [PubMed] [Google Scholar]
  10. Kreft-Jais C., Plouin P. F., Tchobroutsky C., Boutroy M. J. Angiotensin-converting enzyme inhibitors during pregnancy: a survey of 22 patients given captopril and nine given enalapril. Br J Obstet Gynaecol. 1988 Apr;95(4):420–422. doi: 10.1111/j.1471-0528.1988.tb06619.x. [DOI] [PubMed] [Google Scholar]
  11. Larochelle P., Bass M. J., Birkett N. J., De Champlain J., Myers M. G. Recommendations from the Consensus Conference on Hypertension in the Elderly. CMAJ. 1986 Oct 1;135(7):741–745. [PMC free article] [PubMed] [Google Scholar]
  12. Loaldi A., Polese A., Montorsi P., De Cesare N., Fabbiocchi F., Ravagnani P., Guazzi M. D. Comparison of nifedipine, propranolol and isosorbide dinitrate on angiographic progression and regression of coronary arterial narrowings in angina pectoris. Am J Cardiol. 1989 Sep 1;64(8):433–439. doi: 10.1016/0002-9149(89)90417-7. [DOI] [PubMed] [Google Scholar]
  13. Michelson E. L., Frishman W. H., Lewis J. E., Edwards W. T., Flanigan W. J., Bloomfield S. S., Johnson B. F., Lucas C., Freis E. D., Finnerty F. A. Multicenter clinical evaluation of long-term efficacy and safety of labetalol in treatment of hypertension. Am J Med. 1983 Oct 17;75(4A):68–80. doi: 10.1016/0002-9343(83)90138-9. [DOI] [PubMed] [Google Scholar]
  14. Myers M. G., Carruthers S. G., Leenen F. H., Haynes R. B. Recommendations from the Canadian Hypertension Society Consensus Conference on the Pharmacologic Treatment of Hypertension. CMAJ. 1989 May 15;140(10):1141–1146. [PMC free article] [PubMed] [Google Scholar]
  15. Puska P., Iacono J. M., Nissinen A., Korhonen H. J., Vartianinen E., Pietinen P., Dougherty R., Leino U., Mutanen M., Moisio S. Controlled, randomised trial of the effect of dietary fat on blood pressure. Lancet. 1983 Jan 1;1(8314-5):1–5. doi: 10.1016/s0140-6736(83)91556-8. [DOI] [PubMed] [Google Scholar]
  16. Ram C. V., Garrett B. N., Kaplan N. M. Moderate sodium restriction and various diuretics in the treatment of hypertension. Arch Intern Med. 1981 Jul;141(8):1015–1019. [PubMed] [Google Scholar]
  17. Schulte K. L., Meyer-Sabellek W. A., Haertenberger A., Thiede H. M., Roecker L., Distler A., Gotzen R. Antihypertensive and metabolic effects of diltiazem and nifedipine. Hypertension. 1986 Oct;8(10):859–865. doi: 10.1161/01.hyp.8.10.859. [DOI] [PubMed] [Google Scholar]
  18. Todd P. A., Heel R. C. Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure. Drugs. 1986 Mar;31(3):198–248. doi: 10.2165/00003495-198631030-00002. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES